{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:16:40Z","timestamp":1792196200131,"version":"4.4.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Colorectal Dis"],"DOI":"10.1007\/s00384-025-05045-y","type":"journal-article","created":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T06:43:34Z","timestamp":1767422614000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["rs2032582 polymorphism of ATP binding cassette subfamily B member 1 affect the susceptibility of inflammatory bowel disease: a systematical meta-analysis based on 14,876 subjects"],"prefix":"10.1007","volume":"41","author":[{"given":"Hongwei","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hesong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guixiang","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,3]]},"reference":[{"issue":"1","key":"5045_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S2468-1253(19)30333-4","volume":"5","author":"Collaborators GBDIBD","year":"2020","unstructured":"Collaborators GBDIBD (2020) The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol 5(1):17\u201330","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"5045_CR2","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1136\/gutjnl-2024-332523","volume":"74","author":"MM Estevinho","year":"2025","unstructured":"Estevinho MM, Midya V, Cohen-Mekelburg S, Allin KH, Fumery M, Pinho SS et al (2025) Emerging role of environmental pollutants in inflammatory bowel disease risk, outcomes and underlying mechanisms. Gut 74(3):477\u2013486","journal-title":"Gut"},{"issue":"6","key":"5045_CR3","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","volume":"30","author":"D Zheng","year":"2020","unstructured":"Zheng D, Liwinski T, Elinav E (2020) Interaction between microbiota and immunity in health and disease. Cell Res 30(6):492\u2013506","journal-title":"Cell Res"},{"issue":"12","key":"5045_CR4","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.3390\/genes13122388","volume":"13","author":"S Jarmakiewicz-Czaja","year":"2022","unstructured":"Jarmakiewicz-Czaja S, Zielinska M, Sokal A, Filip R (2022) Genetic and epigenetic etiology of inflammatory bowel disease: an update. Genes (Basel) 13(12):2388","journal-title":"Genes (Basel)"},{"issue":"1","key":"5045_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04365-8","volume":"9","author":"Y Momozawa","year":"2018","unstructured":"Momozawa Y, Dmitrieva J, Theatre E, Deffontaine V, Rahmouni S, Charloteaux B et al (2018) IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes. Nat Commun 9(1):2427","journal-title":"Nat Commun"},{"key":"5045_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00367","volume":"7","author":"T Sidiq","year":"2016","unstructured":"Sidiq T, Yoshihama S, Downs I, Kobayashi KS (2016) Nod2: a critical regulator of ileal microbiota and Crohn\u2019s disease. Front Immunol 7:367","journal-title":"Front Immunol"},{"issue":"Supplement_2","key":"5045_CR7","doi-asserted-by":"publisher","first-page":"ii3","DOI":"10.1093\/ecco-jcc\/jjac034","volume":"16","author":"GW Sewell","year":"2022","unstructured":"Sewell GW, Kaser A (2022) Interleukin-23 in the pathogenesis of inflammatory bowel disease and implications for therapeutic intervention. J Crohns Colitis 16(Supplement_2):ii3\u2013ii19","journal-title":"J Crohns Colitis"},{"key":"5045_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116891","volume":"176","author":"W Zhang","year":"2024","unstructured":"Zhang W, Zou M, Fu J, Xu Y, Zhu Y (2024) Autophagy: a potential target for natural products in the treatment of ulcerative colitis. Biomed Pharmacother 176:116891","journal-title":"Biomed Pharmacother"},{"key":"5045_CR9","doi-asserted-by":"crossref","unstructured":"Abraham C, Abreu MT, Turner JR (2022) Pattern recognition receptor signaling and cytokine networks in microbial defenses and regulation of intestinal barriers: implications for inflammatory bowel disease. Gastroenterology 162(6):1602\u201316 e6","DOI":"10.1053\/j.gastro.2021.12.288"},{"key":"5045_CR10","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8813558","volume":"2020","author":"JB Yan","year":"2020","unstructured":"Yan JB, Luo MM, Chen ZY, He BH (2020) The function and role of the Th17\/Treg cell balance in inflammatory bowel disease. J Immunol Res 2020:8813558","journal-title":"J Immunol Res"},{"key":"5045_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1191782","volume":"14","author":"V Navarro-Compan","year":"2023","unstructured":"Navarro-Compan V, Puig L, Vidal S, Ramirez J, Llamas-Velasco M, Fernandez-Carballido C et al (2023) The paradigm of IL-23-independent production of IL-17F and IL-17A and their role in chronic inflammatory diseases. Front Immunol 14:1191782","journal-title":"Front Immunol"},{"issue":"1","key":"5045_CR12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s12079-022-00695-x","volume":"17","author":"A Shahini","year":"2023","unstructured":"Shahini A, Shahini A (2023) Role of interleukin-6-mediated inflammation in the pathogenesis of inflammatory bowel disease: focus on the available therapeutic approaches and gut microbiome. J Cell Commun Signal 17(1):55\u201374","journal-title":"J Cell Commun Signal"},{"key":"5045_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1307394","volume":"11","author":"I Aggeletopoulou","year":"2024","unstructured":"Aggeletopoulou I, Kalafateli M, Tsounis EP, Triantos C (2024) Exploring the role of IL-1beta in inflammatory bowel disease pathogenesis. Front Med (Lausanne) 11:1307394","journal-title":"Front Med (Lausanne)"},{"issue":"12","key":"5045_CR14","first-page":"13916","volume":"13","author":"LM Genaro","year":"2021","unstructured":"Genaro LM, Gomes LEM, Franceschini A, Ceccato HD, de Jesus RN, Lima AP et al (2021) Anti-TNF therapy and immunogenicity in inflammatory bowel diseases: a translational approach. Am J Transl Res 13(12):13916\u201313930","journal-title":"Am J Transl Res"},{"issue":"10","key":"5045_CR15","first-page":"e46833","volume":"15","author":"SK Gara","year":"2023","unstructured":"Gara SK, Guntipalli P, Marzban S, Taqi M, Aryal V, Khan QUA et al (2023) Clinical outcomes of Ustekinumab in inflammatory bowel disease. Cureus 15(10):e46833","journal-title":"Cureus"},{"issue":"1901","key":"5045_CR16","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2023.0074","volume":"379","author":"L Stoeltje","year":"2024","unstructured":"Stoeltje L, Luc JK, Haddad T, Schrankel CS (2024) The roles of ABCB1\/P-glycoprotein drug transporters in regulating gut microbes and inflammation: insights from animal models, old and new. Philos Trans R Soc Lond B Biol Sci 379(1901):20230074","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"4","key":"5045_CR17","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1080\/17425255.2021.1876661","volume":"17","author":"H Bruckmueller","year":"2021","unstructured":"Bruckmueller H, Cascorbi I (2021) ABCB1, ABCG2, ABCC1, ABCC2, and ABCC3 drug transporter polymorphisms and their impact on drug bioavailability: what is our current understanding? Expert Opin Drug Metab Toxicol 17(4):369\u2013396","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"9","key":"5045_CR18","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1111\/bcp.14288","volume":"86","author":"LM Geers","year":"2020","unstructured":"Geers LM, Pozhidaev IV, Ivanova SA, Freidin MB, Schmidt AF, Cohen D et al (2020) Association between 8 P-glycoprotein (MDR1\/ABCB1) gene polymorphisms and antipsychotic drug-induced hyperprolactinaemia. Br J Clin Pharmacol 86(9):1827\u20131835","journal-title":"Br J Clin Pharmacol"},{"issue":"9","key":"5045_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046295","volume":"7","author":"W Shou","year":"2012","unstructured":"Shou W, Wang D, Zhang K, Wang B, Wang Z, Shi J et al (2012) Gene-wide characterization of common quantitative trait loci for ABCB1 mRNA expression in normal liver tissues in the Chinese population. PLoS One 7(9):e46295","journal-title":"PLoS One"},{"key":"5045_CR20","unstructured":"Andrews CA (2010) The hardy-weinberg principle. Nat Educ Knowledge 3(10):65"},{"key":"5045_CR21","doi-asserted-by":"crossref","unstructured":"Seagroatt V, Stratton I (1998) Bias in meta-analysis detected by a simple, graphical test. Test had 10% false positive rate. BMJ 316(7129):470. author reply -1","DOI":"10.1136\/bmj.316.7129.469"},{"key":"5045_CR22","doi-asserted-by":"crossref","unstructured":"Sajid A, Lusvarghi S, Ambudkar SV. The P-Glycoprotein multidrug transporter. In: Drug transporters. pp 199\u2013211","DOI":"10.1002\/9781119739883.ch10"},{"issue":"3","key":"5045_CR23","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/ibd.20030","volume":"13","author":"G Englund","year":"2007","unstructured":"Englund G, Jacobson A, Rorsman F, Artursson P, Kindmark A, Ronnblom A (2007) Efflux transporters in ulcerative colitis: decreased expression of BCRP (ABCG2) and Pgp (ABCB1). Inflamm Bowel Dis 13(3):291\u2013297","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"5045_CR24","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.xphs.2018.09.024","volume":"108","author":"P Erdmann","year":"2019","unstructured":"Erdmann P, Bruckmueller H, Martin P, Busch D, Haenisch S, Muller J et al (2019) Dysregulation of mucosal membrane transporters and drug-metabolizing enzymes in ulcerative colitis. J Pharm Sci 108(2):1035\u20131046","journal-title":"J Pharm Sci"},{"issue":"8","key":"5045_CR25","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1007\/s10620-013-2636-7","volume":"58","author":"N Verma","year":"2013","unstructured":"Verma N, Ahuja V, Paul J (2013) Profiling of ABC transporters during active ulcerative colitis and in vitro effect of inflammatory modulators. Dig Dis Sci 58(8):2282\u20132292","journal-title":"Dig Dis Sci"},{"issue":"130","key":"5045_CR26","first-page":"367","volume":"61","author":"YJ Zhang","year":"2014","unstructured":"Zhang YJ, Wang P, Zhang Y, Zheng YF, Jin JJ, Wang JL (2014) Effects of 5-amino salicylic acid on the expression of multidrug resistance gene in ulcerative colitis. Hepatogastroenterology 61(130):367\u2013372","journal-title":"Hepatogastroenterology"},{"issue":"2\u20133","key":"5045_CR27","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1159\/000179361","volume":"78","author":"H Gutmann","year":"2008","unstructured":"Gutmann H, Hruz P, Zimmermann C, Straumann A, Terracciano L, Hammann F et al (2008) Breast cancer resistance protein and P-glycoprotein expression in patients with newly diagnosed and therapy-refractory ulcerative colitis compared with healthy controls. Digestion 78(2\u20133):154\u2013162","journal-title":"Digestion"},{"key":"5045_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.571997","volume":"11","author":"A Muderrisoglu","year":"2020","unstructured":"Muderrisoglu A, Babaoglu E, Korkmaz ET, Ongun MC, Karabulut E, Iskit AB et al (2020) Effects of genetic polymorphisms of drug transporter ABCB1 (MDR1) and cytochrome P450 enzymes CYP2A6, CYP2B6 on nicotine addiction and smoking cessation. Front Genet 11:571997","journal-title":"Front Genet"},{"issue":"1","key":"5045_CR29","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2217\/14622416.8.1.29","volume":"8","author":"C Kimchi-Sarfaty","year":"2007","unstructured":"Kimchi-Sarfaty C, Marple AH, Shinar S, Kimchi AM, Scavo D, Roma MI et al (2007) Ethnicity-related polymorphisms and haplotypes in the human ABCB1 gene. Pharmacogenomics 8(1):29\u201339","journal-title":"Pharmacogenomics"},{"issue":"7","key":"5045_CR30","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1093\/hmg\/ddg088","volume":"12","author":"S Shifman","year":"2003","unstructured":"Shifman S, Kuypers J, Kokoris M, Yakir B, Darvasi A (2003) Linkage disequilibrium patterns of the human genome across populations. Hum Mol Genet 12(7):771\u2013776","journal-title":"Hum Mol Genet"},{"issue":"2","key":"5045_CR31","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.cgh.2017.05.047","volume":"16","author":"HY Shi","year":"2018","unstructured":"Shi HY, Levy AN, Trivedi HD, Chan FKL, Ng SC, Ananthakrishnan AN (2018) Ethnicity influences phenotype and outcomes in inflammatory bowel disease: a systematic review and meta-analysis of population-based studies. Clin Gastroenterol Hepatol 16(2):190\u20137 e11","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"5045_CR32","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1053\/j.gastro.2020.08.064","volume":"160","author":"EL Barnes","year":"2021","unstructured":"Barnes EL, Loftus EV Jr, Kappelman MD (2021) Effects of race and ethnicity on diagnosis and management of inflammatory bowel diseases. Gastroenterology 160(3):677\u2013689","journal-title":"Gastroenterology"},{"issue":"4","key":"5045_CR33","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1097\/MIB.0000000000000289","volume":"21","author":"LJ Dixon","year":"2015","unstructured":"Dixon LJ, Kabi A, Nickerson KP, McDonald C (2015) Combinatorial effects of diet and genetics on inflammatory bowel disease pathogenesis. Inflamm Bowel Dis 21(4):912\u2013922","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"5045_CR34","doi-asserted-by":"publisher","DOI":"10.1093\/cdn\/nzac110","volume":"6","author":"JE Lee","year":"2022","unstructured":"Lee JE, Kim KS, Koh H, Lee DW, Kang NJ (2022) Diet-induced host-microbe interactions: personalized diet strategies for improving inflammatory bowel disease. Curr Dev Nutr 6(8):nzac110","journal-title":"Curr Dev Nutr"}],"container-title":["International Journal of Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00384-025-05045-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-025-05045-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-025-05045-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T01:50:07Z","timestamp":1767491407000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00384-025-05045-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,3]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5045"],"URL":"https:\/\/doi.org\/10.1007\/s00384-025-05045-y","relation":{},"ISSN":["1432-1262"],"issn-type":[{"value":"1432-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,3]]},"assertion":[{"value":"28 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This review does not require ethical approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish & participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}